Eyal Shamir | Chief Executive Officer |
Ronen Tsimerman | Chief Financial Officer |
Kenneth Tomkovich | Co-Primary Investigator |
Ben Haynor | Alliance Global Partners |
Kemp Dolliver | Brookline Capital Markets |
Welcome to IceCure’s Conference Call on the Financial Results for the First Half of 2022. Management will provide an overview of IceCure’s financial results as well as clinical, commercial, and operational highlights. Participating on the call today are IceCure’s CEO, Eyal Shamir; and CFO, Ronen Tsimerman. They are joined today by Dr. Kenneth Tomkovich, the Co-Primary Investigator for IceCure’s ICE3 ProSense clinical trial on cryoablation of small, low-risk breast cancer.